Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2259525
                    [Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
                    [Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
                    [DatePublished] => 2023-04-17 07:51:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2140538
                    [Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
                    [Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. 
                    [DatePublished] => 2021-11-11 07:59:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2133582
                    [Title] => Merck seeks US authorization for COVID-19 treatment pill
                    [Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
                    [DatePublished] => 2021-10-12 08:35:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1807254
                    [AuthorName] => Sarah Titterton
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1347599
                    [Title] => Studies see new risks for cholesterol drug niacin
                    [Summary] => 
New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.

                    [DatePublished] => 2014-07-18 02:08:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 1308007
                    [Title] => Many Pinoys suffering from neuropathy
                    [Summary] => 
Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.

                    [DatePublished] => 2014-04-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 926523
                    [Title] => 1 in 10 Filipinos suffer infertility - study
                    [Summary] => 
One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

                    [DatePublished] => 2013-04-03 17:06:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1761201
                    [AuthorName] => Tam Noda
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 838600
                    [Title] => Merck Serono marks Neurobion's 50th year
                    [Summary] => 
Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

merck

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2259525
                    [Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
                    [Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
                    [DatePublished] => 2023-04-17 07:51:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2140538
                    [Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
                    [Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. 
                    [DatePublished] => 2021-11-11 07:59:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2133582
                    [Title] => Merck seeks US authorization for COVID-19 treatment pill
                    [Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
                    [DatePublished] => 2021-10-12 08:35:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1807254
                    [AuthorName] => Sarah Titterton
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1347599
                    [Title] => Studies see new risks for cholesterol drug niacin
                    [Summary] => 
New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.

                    [DatePublished] => 2014-07-18 02:08:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 1308007
                    [Title] => Many Pinoys suffering from neuropathy
                    [Summary] => 
Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.

                    [DatePublished] => 2014-04-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 926523
                    [Title] => 1 in 10 Filipinos suffer infertility - study
                    [Summary] => 
One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

                    [DatePublished] => 2013-04-03 17:06:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1761201
                    [AuthorName] => Tam Noda
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 838600
                    [Title] => Merck Serono marks Neurobion's 50th year
                    [Summary] => 
Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest